CLOVIS ONCOLOGY INC's ticker is and the CUSIP is 189464AB6. A total of 32 filers reported holding CLOVIS ONCOLOGY INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $2,000 | 0.0% | 2 | 0.0% | 0.00% | – |
| Q3 2019 | $2,000 | 0.0% | 2 | 0.0% | 0.00% | – |
| Q2 2019 | $2,000 | 0.0% | 2 | 0.0% | 0.00% | – |
| Q1 2019 | $2,000 | 0.0% | 2 | 0.0% | 0.00% | – |
| Q4 2018 | $2,000 | 0.0% | 2 | 0.0% | 0.00% | – |
| Q3 2018 | $2,000 | 0.0% | 2 | 0.0% | 0.00% | – |
| Q2 2018 | $2,000 | 0.0% | 2 | 0.0% | 0.00% | – |
| Q1 2018 | $2,000 | -75.0% | 2 | -66.7% | 0.00% | – |
| Q4 2017 | $8,000 | -42.9% | 6 | -33.3% | 0.00% | – |
| Q3 2017 | $14,000 | +7.7% | 9 | +12.5% | 0.00% | – |
| Q2 2017 | $13,000 | +44.4% | 8 | +33.3% | 0.00% | – |
| Q1 2017 | $9,000 | – | 6 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LINDEN ADVISORS LP | 69,346,000 | $107,321,000 | 3.81% |
| PFM Health Sciences, LP | 34,710,000 | $53,670,000 | 1.06% |
| Partner Investment Management, L.P. | 556,000 | $860,000 | 0.82% |
| Myriad Asset Management Ltd. | 5,000,000 | $7,731,000 | 0.75% |
| SYMPHONY ASSET MANAGEMENT LLC | 4,000,000 | $6,185,000 | 0.69% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 9,074,000 | $14,030,000 | 0.49% |
| CSS LLC/IL | 5,251,000 | $8,112,000 | 0.40% |
| SSI INVESTMENT MANAGEMENT LLC | 2,813,000 | $4,333,000 | 0.37% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 7,131,000 | $11,056,000 | 0.21% |
| D. E. Shaw & Co., Inc. | 27,750,000 | $42,835,000 | 0.07% |